Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

The activity for stock options under the Company’s stock plans for the three months ended March 31, 2021 is as follows:

								Remaining
								weighted-
						Weighted-		average		Per share
						average		contractual		average
				Price per		exercise		terms		intrinsic
	Options			share		price		(in years)		value
Outstanding as of December 31, 2020		955,479		$0.75-$83.30		$	35.49		1.85	$	11.81
Exercised		(205,753	)	0.75-46.66			18.79
Forfeited		—			—		—
Outstanding as of March 31, 2021		749,726		0.81-83.30			40.07		1.96		15.09
Vested and exercisable as of March 31, 2021		749,726		0.81-83.30			40.07		1.96		15.09
Vested and expected to vest as of March 31, 2021		749,726		$0.81-$83.30		$	40.07		1.96	$	15.09

Summary of Restricted Stock Activity

Stock Awards activity for the three months ended March 31, 2021 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2020		245,462			88,458			333,920		$	49.29
Granted		171,340			88,902			260,242			53.14
Vested		(39,293	)		—			(39,293	)		52.58
Forfeited/canceled		(3,742	)		(29,485	)		(33,227	)		48.08
Unvested restricted stock units as of March 31, 2021 ⁽¹⁾		373,767			147,875			521,642		$	50.95
Unvested and expected to vest restricted stock units outstanding as of March 31, 2021								411,867		$	51.09

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2020		42,076			33,355			75,431		$	93.96
Vested		(5,609	)		—			(5,609	)		90.24
Forfeited/canceled		—			(21,510	)		(21,510	)		118.41
Unvested restricted stock awards outstanding as of March 31, 2021 ⁽¹⁾		36,467			11,845			48,312		$	86.52
Unvested and expected to vest restricted stock awards outstanding as of March 31, 2021								38,978		$	85.32

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three months ended March 31, 2021 and March 31, 2020, was as follows:

	Three months ended
	March 31,
	2021		2020
Stock-based compensation expense by type of award:
Stock option plan awards	$	—	$	525
Restricted stock units and restricted stock awards		2,330		2,083
Employee stock purchase plan		186		176
Total stock-based compensation expense	$	2,516	$	2,784

For the three months ended March 31, 2021 and March 31, 2020, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended
	March 31,
	2021		2020
Cost of revenue	$	238	$	229
Research and development		298		320
Sales and marketing		612		612
General and administrative		1,368		1,623
Total stock-based compensation expense	$	2,516	$	2,784